Add-On Keytruda Doubles pCR Rate in Early Breast Cancer

11:30 EST 13 Feb 2020 | MedPageToday

]]>(MedPage Today) -- Escalating preoperative systemic therapy with immunotherapy improved pathologic complete response (pCR) rates for women with high-risk early breast cancer, results of a phase II trial showed. Among 240 women with stage II/III...

Original Article: Add-On Keytruda Doubles pCR Rate in Early Breast Cancer


More From BioPortfolio on "Add-On Keytruda Doubles pCR Rate in Early Breast Cancer"

Quick Search

Relevant Topics

Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Polymerase Chain Reaction (PCR)
PCR (Polymerase Chain Reaction) uses the ability of DNA polymerase (enzymes that create DNA molecules by assembling nucleotides, the building blocks of DNA. These enzymes are essential to DNA replication and usually work in pairs to create two ident...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...